Here's the live share price of J B Chemicals & Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of J B Chemicals & Pharmaceuticals has gained 32.25% CAGR. Over the past year, the corresponding return has been -12.68%.
J B Chemicals & Pharmaceuticals’s current P/E of 38.37x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
J B Chemicals & Pharmaceuticals | -2.32 | -2.14 | -3.07 | 10.60 | -12.68 | 19.54 | 32.25 |
Sun Pharmaceutical Industries | 0.49 | -2.26 | -5.11 | -4.83 | -13.57 | 21.68 | 26.44 |
Divi's Laboratories | 0.52 | -1.02 | -9.43 | 7.50 | 9.92 | 18.00 | 13.79 |
Cipla | -0.28 | -0.82 | 2.90 | 5.98 | -6.64 | 13.52 | 16.50 |
Torrent Pharmaceuticals | -1.37 | -2.40 | 8.62 | 15.45 | 2.18 | 32.67 | 20.35 |
Dr. Reddy's Laboratories | 2.63 | 3.94 | -4.38 | 17.51 | -2.24 | 15.26 | 8.32 |
Mankind Pharma | 1.08 | 4.60 | 8.27 | 17.17 | 3.21 | 21.89 | 12.61 |
Zydus Lifesciences | 2.22 | 4.82 | 6.33 | 17.47 | -7.31 | 40.26 | 22.98 |
Lupin | 5.26 | 2.90 | 2.32 | 3.95 | -9.17 | 44.83 | 16.16 |
Abbott India | -0.65 | -6.10 | -1.81 | 4.61 | 4.78 | 19.99 | 13.39 |
Alkem Laboratories | 2.90 | 1.86 | 13.26 | 16.73 | -13.69 | 19.58 | 13.54 |
Aurobindo Pharma | 5.19 | 2.00 | -4.52 | 0.37 | -29.92 | 25.72 | 6.67 |
Glenmark Pharmaceuticals | 2.18 | 3.28 | 25.67 | 49.43 | 19.74 | 74.71 | 34.18 |
Laurus Labs | 1.69 | 3.76 | 34.34 | 56.24 | 77.17 | 17.47 | 27.44 |
Biocon | -1.47 | -0.49 | 0.84 | 11.01 | -5.37 | 5.74 | -3.58 |
Anthem Biosciences | 0.60 | 10.61 | 14.29 | 14.29 | 14.29 | 4.55 | 2.71 |
GlaxoSmithKline Pharmaceuticals | -0.66 | -0.78 | -16.58 | 3.56 | -5.20 | 24.76 | 9.75 |
Cohance Lifesciences | 6.64 | -0.16 | -1.94 | -14.02 | -18.42 | 26.86 | 22.11 |
Ipca Laboratories | -1.64 | -3.72 | -3.93 | 1.15 | -11.03 | 13.54 | 4.09 |
Gland Pharma | 5.95 | 2.86 | 18.75 | 29.08 | 6.84 | -6.26 | 1.96 |
Over the last one year, J B Chemicals & Pharmaceuticals has declined 12.68% compared to peers like Sun Pharmaceutical Industries (-13.57%), Divi's Laboratories (9.92%), Cipla (-6.64%). From a 5 year perspective, J B Chemicals & Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Day | SMA | EMA |
---|---|---|
5 | 1,718.09 | 1,710.61 |
10 | 1,720.47 | 1,715.34 |
20 | 1,722.66 | 1,716.58 |
50 | 1,697.24 | 1,707.27 |
100 | 1,681.35 | 1,696.88 |
200 | 1,696.21 | 1,699.44 |
In the latest quarter, J B Chemicals & Pharmaceuticals saw a drop in promoter holding to 47.73%, while DII stake increased to 19.62%, FII holding fell to 17.77%, and public shareholding moved down to 14.87% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Kotak Emerging Equity Fund - Regular Plan | 48,16,878 | 1.46 | 830.57 |
Axis Small Cap Fund | 29,84,782 | 2.01 | 514.67 |
Franklin India Smaller Companies Fund | 14,48,723 | 1.85 | 256.32 |
Canara Robeco Small Cap Fund | 13,53,805 | 1.85 | 233.44 |
Kotak Small Cap Fund - Regular Plan | 12,96,204 | 1.28 | 223.5 |
Axis ELSS Tax Saver Fund | 10,87,630 | 0.54 | 187.54 |
Nippon India Pharma Fund | 9,99,649 | 2.06 | 172.37 |
Nippon India Small Cap Fund | 9,91,107 | 0.26 | 170.9 |
Nippon India Multi Cap Fund | 9,49,834 | 0.35 | 163.78 |
Axis Midcap Fund | 9,05,875 | 0.5 | 156.2 |
Date Time | Announcement |
---|---|
Sep 08, 2025, 11:11 PM IST | J B Chemicals & Phar - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulati |
Sep 04, 2025, 10:11 PM IST | J B Chemicals & Phar - Updates on Open Offer |
Sep 02, 2025, 12:09 AM IST | J B Chemicals & Phar - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Aug 31, 2025, 4:39 PM IST | J B Chemicals & Phar - Announcement under Regulation 30 (LODR)-Change in Directorate |
Aug 14, 2025, 7:09 PM IST | J B Chemicals & Phar - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 3722.92 Cr. and Equity Capital is Rs. 15.57 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for J B Chemicals & Pharmaceuticals is ₹1,678.90 as on Sep 15, 2025.
The J B Chemicals & Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of J B Chemicals & Pharmaceuticals is ₹26,290.94 Cr as on Sep 15, 2025.
Today’s highest and lowest price of J B Chemicals & Pharmaceuticals are ₹1,696.45 and ₹1,671.85.
The 52-week high/low is the highest and lowest price at which J B Chemicals & Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of J B Chemicals & Pharmaceuticals is ₹1,998.00 and 52-week low of J B Chemicals & Pharmaceuticals is ₹1,303.00 as on Sep 15, 2025.
The J B Chemicals & Pharmaceuticals has shown returns of -1.25% over the past day, -2.14% for the past month, -3.07% over 3 months, -12.68% over 1 year, 19.54% across 3 years, and 32.25% over 5 years.
P/E ratio of and PB ratio of J B Chemicals & Pharmaceuticals are 38.37 and 8.18 on Sep 15, 2025. While the company gives a dividend yield of 0.92 per annum.